54.159.186.146
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Dry Eye

Dexamethasone ophthalmic insert has potential as non-abusable therapy for allergic conjunctivitis

Due to its sustained 30 day efficacy, intracanalicular dexamethasone insert (Dextenza;) has the potential to be a non-abusable treatment for allergic conjunctivitis, a condition which current standard of care is often linked with steroid abuse, cytotoxic damage, and compliance issues. Data from an analysis of 3 clinical trials evaluating Dextenza...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-